{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:19:59Z","timestamp":1787509199177,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH Office of Rare Diseases Research (ORDR) and the National Center for Advancing Translational Science (NCATS), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","award":["U54HD061221"],"award-info":[{"award-number":["U54HD061221"]}]},{"name":"NIH","award":["DK92921"],"award-info":[{"award-number":["DK92921"]}]},{"name":"Baylor College of Medicine General Clinical Research Center","award":["RR00188"],"award-info":[{"award-number":["RR00188"]}]},{"name":"Eunice Kennedy Shriver National Institute of Child Health & Human Development","award":["HD024064"],"award-info":[{"award-number":["HD024064"]}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ymgme.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T08:48:41Z","timestamp":1404377321000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders"],"prefix":"10.1016","volume":"113","author":[{"given":"Lindsay C.","family":"Burrage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahim","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandesh C.S.","family":"Nagamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.06.005_bb0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/mgme.2001.3156","article-title":"Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients","volume":"72","author":"Burlina","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1203\/00006450-199102000-00009","article-title":"Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion","volume":"29","author":"Brusilow","year":"1991","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.6243418","article-title":"Amino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis","volume":"207","author":"Brusilow","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2014.06.005_bb0045","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1067\/mpd.2001.111836","article-title":"Alternative pathway therapy for urea cycle disorders: twenty years later","volume":"138","author":"Batshaw","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/11591280-000000000-00000","article-title":"Clinical and experimental applications of sodium phenylbutyrate","volume":"11","author":"Iannitti","year":"2011","journal-title":"Drugs R D"},{"key":"10.1016\/j.ymgme.2014.06.005_bb0055","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2014.06.005_bb0060","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1194\/jlr.M900216-JLR200","article-title":"The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response","volume":"50","author":"Basseri","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/hmg\/ddq507","article-title":"Phenylbutyrate therapy for maple syrup urine disease","volume":"20","author":"Brunetti-Pierri","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0070","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3476(95)70030-7","article-title":"Long-term survival of patients with argininosuccinate synthetase deficiency","volume":"127","author":"Maestri","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0075","first-page":"E801","article-title":"Phenylbutyrate-induced glutamine depletion in humans: effect on leucine metabolism","volume":"274","author":"Darmaun","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.06.005_bb0080","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.ymgme.2003.11.017","article-title":"Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients","volume":"81","author":"Scaglia","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.06.005_bb0085","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.ymgme.2010.01.014","article-title":"Establishing a consortium for the study of rare diseases: the Urea Cycle Disorders Consortium","volume":"100","author":"Seminara","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ymgme.2008.05.004","article-title":"Cross-sectional multicenter study of patients with urea cycle disorders in the United States","volume":"94","author":"Tuchman","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0095","series-title":"R: A Language and Environment for Statistical Computing","author":"R.C. Team","year":"2012"},{"key":"10.1016\/j.ymgme.2014.06.005_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/8904_2012_186","article-title":"Amino acid profiles in patients with urea cycle disorders at admission to hospital due to metabolic decompensation","volume":"9","author":"Rodney","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/humu.22513","article-title":"Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patients","volume":"35","author":"Garcia-Cazorla","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.06.005_bb0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1126\/science.1224631","article-title":"Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy","volume":"338","author":"Novarino","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2014.06.005_bb0025","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1073\/pnas.1303220110","article-title":"Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain alpha-ketoacid dehydrogenase kinase","volume":"110","author":"Tso","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T19:22:33Z","timestamp":1538421753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214002042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":18,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1096719214002042"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.06.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}